Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Further is a global healthcare company specializing in serious illness solutions and medical second opinions. Formerly the international division of Best Doctors, the company provides a platform that connects patients with world-leading medical specialists and facilitates access to advanced treatments globally. Further partners with insurance companies and employers to offer critical illness insurance products that include medical concierge services, genomic testing, and cross-border healthcare navigation. Their business model focuses on improving clinical outcomes for complex conditions such as cancer and major organ failure by ensuring patients receive the most accurate diagnoses and cutting-edge therapeutic options regardless of their geographic location.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Further.